SynapCell

RESOURCES

SynapCell-In-vivo-efficacy-Testing-on-CNS-disorders
DOWNLOAD BROCHURE
FAQ-synapcell-In-vivo-efficacy-Testing-on-CNS-disorders
DOWNLOAD FAQ
Youtube-Channel-SynapCell
checkout videos

ADPD 2024

ASENT 2024 – American Society for Experimental Neurotherapeutics

CNS Therapeutics XChange 2023 in Zurich

Society for Neuroscience in Washington, November 2023

SynapCell participates to ECNP Congress and BioJapan Yokohama

CNS Therapeutics XChange 2023 West Coast

Epilepsy Therapies & Diagnostics Development (ETDD)

CNS Therapeutics XChange 2023 East Coast and Essential Tremor Congress

SynapCell Sponsor of ASENT 2023

Society for Neuroscience 2022 – San Diego

CNS Therapeutics Xchange 2022 – Europe Zürich

BioJapan 2022

CNS Therapeutics Xchange 2022 – US West Coast

Synapcell showcased into GEN magazine

NEUROSCIENCE EVENTS IN PARIS, JULY 2022

SynapCell’s experts hit the West Coast road ! [June 2022]

EILAT XVI CONFERENCE ON NEW ANTIEPILEPTIC DRUGS & DEVICES

ADPD 2022: EEG Biomarkers used to evaluate Anti-Dyskinetic effect of drugs in Parkinson’s Disease

ASENT 2022

Synapcell and Reservoir Neuroscience announce collaboration for development of treatment for chronic epilepsy

AES 2021: Partnership with OVID Threapeutics in Epilepsy

CNS Therapeutics Xchange 2021

Society for Neuroscience 2021

IPEG 2021. A Virtual Event

BioJapan 2021 & more!

Let's talk about your next project

Contact the team
Logo-Synapcell
SynapCell
Bâtiment SYNERGY
ZAC ISIPARC
38330 Saint Ismier – France
 
+33 (0) 458 171 583
Linkedin Twitter Youtube

About

biomarkers

FOCUS

  • EPILEPSY
  • PARKINSON'S DISEASE​

OPEN INNOVATION

CAPABILITIES

SYNAPCELL 2022 © – All Rights Reserved